4
Changes in Ownership
Celldex Therapeutics, Inc. Filed Acc 0001415889-22-008767
SR. VP & CCO sold 15,328 shares at $37.71 ($578,048)
- SR. VP & CCO acquired 15,328 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wright Richard M. SR. VP & CCO | 2022-08-15 | Option exercise | +15,328 | $10.38 | $159,105 | 15,536 | D |
| Wright Richard M. SR. VP & CCO | 2022-08-15 | Sale | −15,328 | $37.71 | $578,048 | 208 | D |
| Derivatives | |||||||
| Wright Richard M. SR. VP & CCO | 2022-08-15 | Option exercise · Incentive Stock Option | −15,328 | 26,672 | D | ||
| Open-market sales · 15,328 sh · avg $37.71 · $578,048 | |||||||
Loading xslF345X03/form4-08172022_010827.xml…